Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117066) titled 'A comparative study of hybutimibe plus atorvastatin versus ezetimibe plus atorvastatin in patients with metabolic syndrome complicated by ischemic stroke' on Jan. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shenzhen Second People's Hospital
Condition:
Metabolic syndrome with ischemic stroke
Intervention:
control group:Ezetimibe 10mg combined with Atorvastatin 20mg, once daily.
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-09-07
Target Sample Size: control group:125;Experimental Group:125;
Countries of Recruitment:
China
To know more, visit ...